Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Apr 1, 2014 (13 years ago)

HydrOXYzine Hydrochloride Oral Solution

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Impurity/Degradation Specification; out-of-specification result for one individual unknown impurity at the 24-month room temperature stability test station.

Cause type: Temperature excursion

The product was stored or shipped outside its labeled temperature range. Heat or freezing can degrade a drug without any visible change, so it may be weaker than labeled. All temperature excursion recalls.

What was recalled

HydrOXYzine Hydrochloride Oral Solution, USP, 10 mg / 5mL, Net Wt 16 fl oz (473 mL), NDC 50383-796-16, Rx Only, Manufactured by: Hi-Tech Pharmacal Co., Inc. Amityville, NY 11701, ALSO LABELED AS HydrOXYzine HCl Oral Solution, USP, 10 mg / 5 mL, Net Wt 16 fl oz (473 mL), NDC 10702-052-16, Rx Only, Manufactured for: KVK-TECH, INC. NEWTOWN, PA 18940, MADE IN USA, Manufactured by: Hi-Tech Pharmacal Co., Inc. Amityville, NY 11701.

Affected NDCs 10702-0052-16 50383-0796-16

Compare with the code on your package — it is the most precise check available.

Drug: Hydroxyzine

Recalling firm
Hi-Tech Pharmacal Co., Inc.
NDC code
50383-796-16
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0048-2015 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Hydroxyzine recalls

See all
Class II · Moderate risk

Hydroxyzine Hydrochloride Oral Solution

Failed Impurities/Degradation Specification: OOS for the following - unknown degradant/impurity, 4-chorobenzophenone, and for total impurities.

Terminated Impurity / degradation Morton Grove Pharmaceuticals, Inc. NDC 60432-150-04 D-0174-2021
Class II · Moderate risk

HydrOXYzine HYDROCHLORIDE SYRUP

CGMP Deviations: cleaning procedures during manufacturing caused out of specification results for unknown impurities.

Terminated Impurity / degradation Lannett Company, Inc. NDC 54838-502-80 D-0083-2019

Other recalls by Hi-Tech Pharmacal Co., Inc.

All 2014 recalls
Class III · Low risk

Acyclovir Oral Suspension

Failed Stability Specification; product viscosity and or pH are below specification.

Terminated Stability / shelf life Hi-Tech Pharmacal Co., Inc. NDC 50383-810-16 D-389-2014
Class III · Low risk

Clobetasol Propionate Cream

Labeling: Label Mix-up; some cartons labeled as Clobetasol Propionate Cream USP contain tubes labeled as Clobetasol Propionate Gel USP. The actual product in the tube is Clobetasol Propionate Cream USP

Terminated Labeling / mix-up Hi-Tech Pharmacal Co., Inc. NDC 50383-267-15 D-888-2013